FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Digitoxin 100microgram tablets (Unichem Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Motilium 30mg suppositories (Zentiva Pharma UK Ltd) 10 suppository 2 x 5 suppositories VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Digitoxin 100microgram tablets (Celltech Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptomycin 1g powder for solution for injection vials (Celltech Pharmaceuticals Ltd) 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptomycin 1g powder for solution for injection vials (Special Order) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Digitoxin 100microgram tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cuticell Contact dressing 5cm x 7.5cm (BSN medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cuticell Contact dressing 7.5cm x 10cm (BSN medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cuticell Contact dressing 10cm x 18cm (BSN medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 7.5cm x 10cm 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 5cm x 7.5cm 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cuticell Contact dressing 5cm x 7.5cm (BSN medical Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cuticell Contact dressing 7.5cm x 10cm (BSN medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cuticell Contact dressing 7.5cm x 10cm (BSN medical Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cuticell Contact dressing 10cm x 18cm (BSN medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cuticell Contact dressing 10cm x 18cm (BSN medical Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cuticell Contact dressing 5cm x 7.5cm (BSN medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nelaton catheter paediatric 5Ch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nelaton catheter paediatric 5Ch 1 catheter VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
WyCath uncoated catheter paediatric 5Ch WUP05 (WyMedical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nelaton catheter paediatric 5Ch 30 catheter VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Self-Cath catheter paediatric 5Ch 305 (Mentor Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Self-Cath catheter paediatric 5Ch 305 (Mentor Medical Ltd) 30 catheter VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Self-Cath catheter paediatric 5Ch 305 (Mentor Medical Ltd) 1 catheter VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
WyCath uncoated catheter paediatric 5Ch WUP05 (WyMedical Ltd) 1 catheter VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
WyCath uncoated catheter paediatric 5Ch WUP05 (WyMedical Ltd) 30 catheter VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arachis oil 130ml enema (Ennogen Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arachis oil 130ml enema (Ennogen Healthcare Ltd) 1 enema VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Procyclidine hydrochloride 10mg/2mL injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Procyclidine 10mg/2ml solution for injection ampoules (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Kemadrin 10mg/2ml solution for injection ampoules (Auden McKenzie Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Procyclidine 10mg/2ml solution for injection ampoules 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Kemadrin 10mg/2ml solution for injection ampoules (Auden McKenzie Ltd) 5 ampoule 5 x 2ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Procyclidine 10mg/2ml solution for injection ampoules (Accord Healthcare Ltd) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Isopropyl alcohol 70% liquid (Ennogen Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Isopropyl alcohol 70% liquid (Ennogen Healthcare Ltd) 500 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Diphtheria / Tetanus / Pertussis (acellular component) / Poliomyelitis (inactivated) / Haemophilus type b conjugate vaccine (adsorbed) powder and suspension for suspension for injection 0.5ml pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diphtheria / Tetanus / Pertussis (acellular component) / Poliomyelitis (inactivated) / Haemophilus type b conjugate vaccine (adsorbed) powder and suspension for suspension for injection 0.5ml pre-filled syringes 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Infanrix-IPV + Hib vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Infanrix-IPV + Hib vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes (GlaxoSmithKline) 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Algi-White Standard dressing 15cm x 15cm (Anser Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Algi-White Dense dressing 15cm x 15cm (Anser Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dario lancets 0.31mm/30gauge (Farla Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Algi-White Standard dressing 15cm x 15cm (Anser Medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Algi-White Dense dressing 15cm x 15cm (Anser Medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dario lancets 0.31mm/30gauge (Farla Medical Ltd) 100 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Procyclidine 10mg/2ml solution for injection ampoules (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Procyclidine 10mg/2ml solution for injection ampoules (Alliance Healthcare (Distribution) Ltd) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sulfamethoxypyridazine 500mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sulfamethoxypyridazine 500mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sulfamethoxypyridazine 500mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely diazepam 10 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely distigmine 5 milligram/1 each conventional release oral tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Naloxone hydrochloride 400mcg/mL injection solution 2mL prefilled syringe VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Estradiol 50mg implant 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Estradiol 50mg implant (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diazepam 10mg suppositories 6 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Estradiol 50mg implant (Organon Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diazepam 10mg suppositories (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Naloxone 800micrograms/2ml solution for injection pre-filled syringes 1 pre-filled disposable injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Diazepam 10mg suppositories 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Distigmine bromide 5mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ubretid 5mg tablets (Aventis Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Estradiol 50mg implant (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Valclair 10mg suppositories (B & S Durbin) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Distigmine bromide 5mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Estradiol 50mg implant (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Distigmine bromide 5mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Minijet naloxone 800micrograms/2ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Estradiol 50mg implant (A A H Pharmaceuticals Ltd) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Minijet naloxone 800micrograms/2ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) 1 pre-filled disposable injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Estradiol 50mg implant (Organon Pharma (UK) Ltd) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ubretid 5mg tablets (Aventis Pharma) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Estradiol 50mg implant (Unichem Plc) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Estradiol 50mg implant (Special Order) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Valclair 10mg suppositories (B & S Durbin) 6 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Distigmine bromide 5mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diazepam 10mg suppositories (Special Order) 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium fusidate 500mg powder and solvent for infusion vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely chlorpropamide 100 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely testosterone 200 milligram/1 each prolonged-release subcutaneous implant (clinical drug) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpropamide 100mg tablets (The Boots Company) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium fusidate 500mg powder and solvent for solution for injection vials (LEO Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpropamide 100mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium fusidate 500mg powder and solvent for solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpropamide 100mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium fusidate 500mg powder and solvent for solution for infusion vials (Essential Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpropamide 100mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 200mg implant 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 200mg implant (Organon Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fucidin 500mg powder and solvent for solution for injection vials (LEO Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium fusidate 500mg powder and solvent for solution for injection vials (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 200mg implant (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 200mg implant (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 200mg implant (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium fusidate 500mg powder and solvent for solution for injection vials (LEO Pharma) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 200mg implant (A A H Pharmaceuticals Ltd) 1 device VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium fusidate 500mg powder and solvent for solution for infusion vials (Essential Pharma Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpropamide 100mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpropamide 100mg tablets (The Boots Company) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 60 of 86 Next End

This concept is not in any reference sets

Back to Start